pmed.1004097.g001.tif (580.91 kB)
Study flow chart showing study design and the attrition of participants at each step of the analysis.
figure
posted on 2022-09-12, 19:08 authored by Jean de Dieu Tapsoba, Jane Cover, Christopher Obong’o, Martha Brady, Tim R. Cressey, Kira Mori, Gordon Okomo, Edward Kariithi, Rael Obanda, Daniel Oluoch-Madiang, Ying Qing Chen, Paul Drain, Ann DuerrMost (246/302, 81%) AGYW interviewed at follow-up had attended at least 1 PrEP dispensation visit between the 2 interviews. Fifty-six had no record of attendance at interim PrEP refill visits, including 21 of the 197 AGYW who reported they were continuing PrEP. This left 176 of the AGYW who attended Interview 2 who met our definition of PrEP persistence (176/302, 58.3%, [95% CI 52.7–63.8] (Figs 1 and 2A and Table A in S1 Table). AGYW, adolescent girls and young women; CI, confidence interval; DBS, dried blood spot; PrEP, pre-exposure prophylaxis.
History
Usage metrics
Categories
Keywords
population yet accountinterim refill visitadjusted odds ratio24 years representmale condom useinjectable contraceptive usealthough oral pre8 ]) metreported continuing prepinitiated prep 2tenofovir disoproxil fumaratemultiple sex partners336 agyw participatingprep use conducted3 months later3 %, 95use prepprep use3 monthsalthough almost88 ])using preptaking prepprep programsyoung womenxlink ">unadjusted analysisstill activesecond interviewsaharan africareceive benefitpoor adherenceoptimal candidatesmodel accountinglevels consistenthighly effectivehigher selffirst interviewexpressed intentionexposure prophylaxiscontinued attendanceconfidence intervalcompleted interviewsci 77ci 52among agywagyw mayagyw believesages 15>- value5 ])13 ],
